Overview

Gender

male

Investor Type

Investment Partner

Thilo Schroeder, PhD, is Partner at Nextech Invest a global venture fund focused on investing in oncology companies. Prior to joining Nextech Invest in 2012, Dr. Schroeder was president of SiROP Global, a web based technology that connects universities in Europe and world-wide. While starting SiROP, Dr. Schroeder has worked in research specializing on the development of Designed Ankyrin Repeat Protein (DARPins) as specific protein inhibitors and has acquired expertise in molecular biology as an Intern at Micromet Ltd. (now Amgen) and during his studies at the University of Sydney

Dr. Schroeder currently serves as board member of SiROP Global and observer of the board of Tracon Pharmaceuticals. He holds a PhD in biochemistry from the University of Zurich in Switzerland, a MSc in biotechnology from the Ecole de Supérieure de Biotechnologie de Strasbourg in France, and a BSc in biology from the Technical University of Darmstadt in Germany.